Viridian Therapeutics, Inc. (FRA:1S1)

Viridian Therapeutics Statistics

Total Valuation

FRA:1S1 has a market cap or net worth of EUR 2.58 billion. The enterprise value is 2.34 billion.

Market Cap	2.58B
Enterprise Value	2.34B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	95.44M
Shares Outstanding	n/a
Shares Change (YoY)	+34.66%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	93.11%
Float	90.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	42.80
PB Ratio	6.02
P/TBV Ratio	9.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.21
EV / Sales	38.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.42

Financial Position

The company has a current ratio of 11.28, with a Debt / Equity ratio of 0.05.

Current Ratio	11.28
Quick Ratio	11.06
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	-108.22

Financial Efficiency

Return on equity (ROE) is -49.89% and return on invested capital (ROIC) is -32.60%.

Return on Equity (ROE)	-49.89%
Return on Assets (ROA)	-30.40%
Return on Invested Capital (ROIC)	-32.60%
Return on Capital Employed (ROCE)	-62.33%
Revenue Per Employee	421,912
Profits Per Employee	-1.46M
Employee Count	143
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +32.40% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+32.40%
50-Day Moving Average	20.62
200-Day Moving Average	15.28
Relative Strength Index (RSI)	75.68
Average Volume (20 Days)	2

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.98

Income Statement

In the last 12 months, FRA:1S1 had revenue of EUR 60.33 million and -209.08 million in losses. Loss per share was -2.57.

Revenue	60.33M
Gross Profit	-213.84M
Operating Income	-279.65M
Pretax Income	-257.37M
Net Income	-209.08M
EBITDA	-279.26M
EBIT	-279.65M
Loss Per Share	-2.57

Balance Sheet

The company has 418.39 million in cash and 20.63 million in debt, giving a net cash position of 397.77 million.

Cash & Cash Equivalents	418.39M
Total Debt	20.63M
Net Cash	397.77M
Net Cash Per Share	n/a
Equity (Book Value)	428.68M
Book Value Per Share	3.26
Working Capital	444.23M

Cash Flow

In the last 12 months, operating cash flow was -277.82 million and capital expenditures -314,499, giving a free cash flow of -278.14 million.

Operating Cash Flow	-277.82M
Capital Expenditures	-314,499
Free Cash Flow	-278.14M
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-463.52%
Pretax Margin	-426.58%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:1S1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.66%
Shareholder Yield	-34.66%
Earnings Yield	-8.10%
FCF Yield	-10.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 13, 2020. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Nov 13, 2020
Split Type	Reverse
Split Ratio	0.0666666667

Scores

FRA:1S1 has an Altman Z-Score of 7.79 and a Piotroski F-Score of 2.

Altman Z-Score	7.79
Piotroski F-Score	2